T. gondii induces neutrophil activation and NET formation. (A to C) Neutrophil absolute counts in whole blood (A), scatter dot plots of the activation marker CD66b (B), and frequency of CD66b+ CD16+ cells (C) in PBMCs from HDs (n = 9 to 11) and acutely (n = 11 to 21) and chronically (n = 11 to 21) T. gondii-infected patients. Each pair connected by a line represents a single individual. (D) Representative transmission electron microscopy images from a T. gondii active infection and a T. gondii opsonized infection of neutrophils from HDs. Bars, 500 nm. (E) Expression of CD66b, CD11b, CD15, CD62L, and CD88 by neutrophils from HDs in medium alone (n = 6 to 13) or stimulated with T. gondii tachyzoites (n = 6 to 14). (F) Relative expression of CD66b by neutrophils from HDs in medium alone or stimulated with T. gondii tachyzoites without (Tg) or with (Tg+MycB) mycalolide B pretreatment (n = 6). (G) Percentage of neutrophils infected for 4 h with T. gondii or T. gondii pretreated with mycalolide B (3 μM, 30 min) (n = 6). (H) Relative CD66b expression in the different subpopulations (Tg positive and negative) from panel G. (I) Representative immunofluorescence microscopy and (J) scatter dot plots (n = 6) of neutrophils from HDs in medium alone (Control), exposed to T. gondii RH expressing YFP with or without pretreatment with mycalolide B (3 μM, 30 min), or stimulated with 25 nM Phorbol 12-myristate 13-acetate (PMA) for 3 h. Cells were stained with Hoechst and anti-human neutrophil elastase (NE). Bars, 25 μm. (K) Neutrophil extracellular ROS production was measured by chemiluminescence (relative light units [RLU]) for 60 min in neutrophils from HDs that were unstimulated (n = 5) or stimulated with T. gondii (n = 5). The differences are relative to the control. The T. gondii-neutrophil ratio was 3:1. Data are medians and interquartile ranges. *, 0.05 > P > 0.01; **, 0.01 > P > 0.001; ***, 0.001 > P > 0.0001; ****, P < 0.0001; ns, not significant.